NDC 0469-0125 – Xtandi

Enzalutamide 40 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC0469-0125

Product details

Brand name
Xtandi
Generic name
enzalutamide
Labeler
Astellas Pharma US, Inc.
Dosage form
Capsule
Route
Oral
Marketing category
NDA · NDA203415
Marketed since
August 31, 2012
Listing expires
December 31, 2027
Pharmacologic class
Androgen Receptor Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Xtandi →

Package NDC codes (1)

Package NDCDescriptionSince
0469-0125-991 BOTTLE in 1 CARTON (0469-0125-99) / 120 CAPSULE in 1 BOTTLEAug 31, 2012

Other Xtandi products